Eruptive haemangioma associated with HIV therapy and mitochondrial pathology

References

• Nolan D, Hammond E, James I, et al. Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level. Antivir Ther 2003; 8: 617–626
   PubMed Web of Science ®Google Scholar
• Nolan D, Hammond E, Martin A, et al. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy: insights into the pathogenesis of antiretroviral therapy-associated lipodystrophy. AIDS 2003; 17: 1329–1338
   PubMed Web of Science ®Google Scholar
• Brinkman K, Smeitink J, Romijn J, et al. Mitochondrial toxicity induced by nucleoside analogue reverse transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral therapy-related lipodystrophy. Lancet 1999; 354: 112–115
   Google Scholar
• Kosmiski L A, Kuritzkes D R, Lichtenstein K A, et al. Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome. AIDS 2001; 15: 1993–2000
   PubMed Web of Science ®Google Scholar
• Heath K V, Hogg R S, Chan K J, et al. Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database. AIDS 2001; 15: 231–239
   PubMed Web of Science ®Google Scholar
• Dank J P, Colven R. Protease inhibitor-associated angiolipomatosis. J Am Acad Dermatol 2000; 42: 129–131
   Google Scholar
• Bornhövd E, Sakrauski A K, Brühl H, Walli R, Plewig G, Röcken M. Multiple circumscribed subcutaneous lipomas associated with use of human immunodeficiency virus protease inhibitors?. Br J Dermatol 2000; 143: 1097–1131
   Google Scholar
• Daudén E, Álvarez S, García-Díez A. Eruptive angiolipomas associated with antiretroviral therapy. AIDS 2002; 16: 805–806
   Google Scholar
• Klopstock T, Naumann M, Schalke B, et al. Multiple symmetric lipomatosis: abnormalities in complex IV and multiple deletions in mitochondrial DNA. Neurology 1994; 44: 862–866
   Google Scholar
• Berkovic S F, Andermann F, Shoubridge E A, et al. Mitochondrial dysfunction in multiple symmetric lipomatosis. Ann Neurol 1991; 29: 566–599
   Google Scholar
• Suzuki Y, Nishimaki K, Taniyama M, et al. Lipoma and opthalmoplegia in mitochondrial diabetes associated with small heteroplasmy level of 3243 tRNA(Leu(UUR)) mutation. Diabetes Res Clin Pract 2004; 63: 225–229
   Google Scholar
• Vila M R, Gamez J, Solano A, et al. Uncoupling protein-1 mRNA expression in lipomas from patients bearing pathogenic mitochondrial DNA mutations. Biochem Biophys Res Commun 2000; 278: 800–802
   Google Scholar
• Allen P, Enzinger F. Hemangioma of skeletal muscle. An analysis of 89 cases. Cancer 1972; 29: 8–22
   PubMed Web of Science ®Google Scholar
• Razon M J, Kraling B M, Mulliken J B, et al. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation 1998; 5: 189–195
   Google Scholar
• Tan S T, Wallis R A, He Y, Davis P F. Mast cells and hemangioma. Plast Reconstr Surg 2004; 113: 999–1011
   PubMed Web of Science ®Google Scholar
• Kempson R L, Fletcher C DM, Evan H L, et al. Tumours of the Soft Tissues. AFIP Atlas of Tumor Pathology3rd Series, Fascicle 30. AFIP, Washington, DC 2001; 335–336
   Google Scholar
• Wiess S, Goldblum J. Enzinger and Wiess's Soft Tissue Tumours4th ed. St Louis, Mosby 2001; 853–855, 874
   Google Scholar
• Wild A T, Raab P, Krauspe R. Hemangioma of skeletal muscle. Arch Orthop Trauma Surg 2000; 120: 139–143
   PubMed Web of Science ®Google Scholar
• Moran C A, Suster S. Mediastinal hemangiomas: a study of 18 cases with emphasis on the spectrum of morphological features. Hum Pathol 1995; 26: 416–421
   Google Scholar
• Hasan Q, Tan S T, Gush J, et al. Altered mitochondrial cytochrome b gene expression during the regression of hemangioma. Plastic Reconstr Surg 2001; 108: 1471–1476
   PubMedGoogle Scholar
• Tornero C, Alberola J, Tamarit A, et al. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals. Clin Microbiol Infect 2006; 12: 555–560
   Google Scholar
• Stone S F, Price P, Keane N M, et al. Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART. HIV Med 2002; 3: 21–27
   PubMedGoogle Scholar
• Lagathu C, Kim M, Maachi M, et al. HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo. Biochimie 2005; 87: 65–71
   PubMed Web of Science ®Google Scholar
• Hammond E, Nolan D, McKinnon E, et al. Assessing the contribution of ART, HIV and host factors to adipose tissue changes occurring in HIV-infected individuals: risk profile for lipoatrophy. Antivir Ther 2005; 10: L4
   Web of Science ®Google Scholar
• Nakagami H, Morishita R, Maeda K, et al. Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb 2006; 13: 77–81
   PubMed Web of Science ®Google Scholar
• Qurratulain H, Tan T, Gush J, et al. Steroid therapy of a proliferating hemangioma: histochemical and molecular changes. Pediatrics 2000; 105: 117–120
   Google Scholar
• Warburg O. Metabolism of Tumours. Arnold Constable, London 1930
   Google Scholar
• Pedersen P L. Tumour mitochondria and the bioenergetics of cancer cells. Prog Exp Tumour Res 1978; 22: 190–274
   PubMedGoogle Scholar
• Zhu W, Qin W, Sauter E R. Large-scale mitochondrial DNA deletion mutations and nuclear genome instability in human breast cancer. Cancer Detect Prev 2004; 8: 119–126
   Google Scholar
• Szewczyk A, Wojtczak L. Mitochondria as a pharmacological target. Pharm Review 2002; 54: 101–127
   PubMed Web of Science ®Google Scholar
• Weissig V, Torchilin V. Cationic bolasomes with delocalized charge centres as mitochondrial-specific DNA delivery systems. Adv Drug Deliv Rev 2001; 9: 127–149
   Google Scholar
• Yang J H, Lee H C, Chung J G, Wei Y H. Mitochondrial DNA mutations in light-associated skin tumours. Anticancer Res 2004; 4: 1753–1758
   Google Scholar